TY - JOUR
T1 - Strain-Release Heteroatom Functionalization
T2 - Development, Scope, and Stereospecificity
AU - Lopchuk, Justin M.
AU - Fjelbye, Kasper
AU - Kawamata, Yu
AU - Malins, Lara R.
AU - Pan, Chung Mao
AU - Gianatassio, Ryan
AU - Wang, Jie
AU - Prieto, Liher
AU - Bradow, James
AU - Brandt, Thomas A.
AU - Collins, Michael R.
AU - Elleraas, Jeff
AU - Ewanicki, Jason
AU - Farrell, William
AU - Fadeyi, Olugbeminiyi O.
AU - Gallego, Gary M.
AU - Mousseau, James J.
AU - Oliver, Robert
AU - Sach, Neal W.
AU - Smith, Jason K.
AU - Spangler, Jillian E.
AU - Zhu, Huichin
AU - Zhu, Jinjiang
AU - Baran, Phil S.
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Driven by the ever-increasing pace of drug discovery and the need to push the boundaries of unexplored chemical space, medicinal chemists are routinely turning to unusual strained bioisosteres such as bicyclo[1.1.1]pentane, azetidine, and cyclobutane to modify their lead compounds. Too often, however, the difficulty of installing these fragments surpasses the challenges posed even by the construction of the parent drug scaffold. This full account describes the development and application of a general strategy where spring-loaded, strained C-C and C-N bonds react with amines to allow for the “any-stage” installation of small, strained ring systems. In addition to the functionalization of small building blocks and late-stage intermediates, the methodology has been applied to bioconjugation and peptide labeling. For the first time, the stereospecific strain-release “cyclopentylation” of amines, alcohols, thiols, carboxylic acids, and other heteroatoms is introduced. This report describes the development, synthesis, scope of reaction, bioconjugation, and synthetic comparisons of four new chiral “cyclopentylation” reagents.
AB - Driven by the ever-increasing pace of drug discovery and the need to push the boundaries of unexplored chemical space, medicinal chemists are routinely turning to unusual strained bioisosteres such as bicyclo[1.1.1]pentane, azetidine, and cyclobutane to modify their lead compounds. Too often, however, the difficulty of installing these fragments surpasses the challenges posed even by the construction of the parent drug scaffold. This full account describes the development and application of a general strategy where spring-loaded, strained C-C and C-N bonds react with amines to allow for the “any-stage” installation of small, strained ring systems. In addition to the functionalization of small building blocks and late-stage intermediates, the methodology has been applied to bioconjugation and peptide labeling. For the first time, the stereospecific strain-release “cyclopentylation” of amines, alcohols, thiols, carboxylic acids, and other heteroatoms is introduced. This report describes the development, synthesis, scope of reaction, bioconjugation, and synthetic comparisons of four new chiral “cyclopentylation” reagents.
UR - http://www.scopus.com/inward/record.url?scp=85014148956&partnerID=8YFLogxK
U2 - 10.1021/jacs.6b13229
DO - 10.1021/jacs.6b13229
M3 - Article
SN - 0002-7863
VL - 139
SP - 3209
EP - 3226
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 8
ER -